Business Description
Innoveren Scientific Inc
NAICS : 541714
SIC : 2834
ISIN : US58504H1014
Description
Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | -13.8 | |||||
| Debt-to-Equity | -0.41 | |||||
| Debt-to-EBITDA | -1.58 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -73.9 | |||||
| 3-Year EBITDA Growth Rate | 51.7 | |||||
| 3-Year EPS without NRI Growth Rate | 52.4 | |||||
| 3-Year FCF Growth Rate | 63 | |||||
| 3-Year Book Growth Rate | 44.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 19.36 | |||||
| 9-Day RSI | 32.05 | |||||
| 14-Day RSI | 39.13 | |||||
| 6-1 Month Momentum % | 10900 | |||||
| 12-1 Month Momentum % | -98.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.08 | |||||
| Quick Ratio | 0.08 | |||||
| Cash Ratio | 0.06 | |||||
| Days Payable | 383688 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -83.7 | |||||
| Shareholder Yield % | -9605 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -202.65 | |||||
| ROA % | -945.19 | |||||
| ROIC % | -38.9 | |||||
| ROC (Joel Greenblatt) % | -15005.32 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.01 | |||||
| EV-to-EBIT | -1.54 | |||||
| EV-to-EBITDA | -1.55 | |||||
| EV-to-Revenue | 9.6 | |||||
| EV-to-FCF | -4.74 | |||||
| Earnings Yield (Greenblatt) % | -64.94 | |||||
| FCF Yield % | -6557.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IVRN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Innoveren Scientific Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.453 | ||
| EPS (TTM) ($) | -4.33 | ||
| Beta | 888.56 | ||
| Volatility % | 99935.98 | ||
| 14-Day RSI | 39.13 | ||
| 14-Day ATR ($) | 0.00597 | ||
| 20-Day SMA ($) | 0.026705 | ||
| 12-1 Month Momentum % | -98.31 | ||
| 52-Week Range ($) | 0.0003 - 3.7315 | ||
| Shares Outstanding (Mil) | 0.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Innoveren Scientific Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Innoveren Scientific Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Innoveren Scientific Inc Frequently Asked Questions
What is Innoveren Scientific Inc(IVRN)'s stock price today?
The current price of IVRN is $0.02. The 52 week high of IVRN is $3.73 and 52 week low is $0.00.
When is next earnings date of Innoveren Scientific Inc(IVRN)?
The next earnings date of Innoveren Scientific Inc(IVRN) is .
Does Innoveren Scientific Inc(IVRN) pay dividends? If so, how much?
Innoveren Scientific Inc(IVRN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers